Recent Quotes
My Watchlist
Indicators
New Hampshire Stocks
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Moderna Inc (NQ: MRNA )

101.29 -0.71 (-0.70%)
Streaming Delayed Price Updated: 1:25 PM EDT, Apr 19, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,147,964
Open 102.37
Bid (Size) 101.29 (1)
Ask (Size) 101.39 (5)
Prev. Close 102.00
Today's Range 101.05 - 103.80
52wk Range 62.55 - 144.43
Shares Outstanding 382,000,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Moderna Options Trading: A Deep Dive into Market Sentiment
Via Benzinga
Moderna to Report First Quarter 2024 Financial Results on Thursday, May 2, 2024
Via ACCESSWIRE

Performance

YTD
-9.96%
-9.96%
1 Month
-3.63%
-3.63%
3 Month
+2.24%
+2.24%
6 Month
+22.97%
+22.97%
1 Year
-29.08%
-29.08%

More News

Read More
Johnson & Johnson Shows Focus On Strengthening Its Business Upon Its Consumer Health Unit Spinoff
Via Benzinga
2 Artificial Intelligence (AI) in Healthcare Stocks to Buy and Hold for Great Long-Term Potential
Via The Motley Fool
Topics Artificial Intelligence
Exposures Artificial Intelligence
2 Stocks Down 30% to Buy Right Now
Via The Motley Fool
Bill Gates Called For A 'Universal Flu Vaccine,' Now The CDC Director Says The Organization Is 'Activated' After Issuing Bird Flu Alert
Via Benzinga
$1000 Invested In Moderna 5 Years Ago Would Be Worth This Much Today
Via Benzinga
A Closer Look at Moderna's Options Market Dynamics
Via Benzinga
Moderna Inc. (NASDAQ: MRNA) Leading the Way in Tuesday Trading Based on Percentage Gain
Via Investor Brand Network
1 New Green Flag for Moderna and Merck Stock
Via The Motley Fool
3 Pharma Stocks to Sell in April Before They Crash & Burn
Via InvestorPlace
If You Can Only Buy One Biotech Stock in April, It Better Be One of These 3 Names
Via InvestorPlace
Declining COVID-19 Vaccine Sales Pinches Moderna, Pauses Kenya Vaccine Plant Plans
Via Benzinga
Exposures COVID-19
The Pharmaceutical Industry Finds Itself At A Historical Crossroads
Via Benzinga
Election Year Encore: Can 2020’s Top 7 Stock Winners Repeat Their Performance in 2024?
Via InvestorPlace
Why Is Moderna Stock Trading Higher On Tuesday?
Via Benzinga
Stocks Fall Ahead Of Key Inflation Data, Gold Defends Record Highs; Bitcoin Stumbles Below $70,000: What's Driving Markets Tuesday?
Via Benzinga
Topics Economy
Exposures Interest Rates
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Why Tilray Brands Shares Are Trading Lower By Around 22%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
BlackBerry, Nurix Therapeutics, Tesla And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
Topics Stocks
Exposures US Equities
Missed Out on Eli Lilly? 2 Healthcare Stocks With Big Catalysts on the Horizon.
Via The Motley Fool
Bull Market and Beyond: 3 Stocks Just Waiting to Soar
Via The Motley Fool
3 Healthcare Stocks Short Sellers Are Prescribing for Trouble
Via InvestorPlace
Moderna's Vaccines Day 2024: A Glimpse into the Future of Infectious Disease Prevention
Via Benzinga
The 3 Most Undervalued Biotech Stocks to Buy in April 2024
Via InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.